COV: Analysis & Opinions

  1. It Gets A Little Harder From Here For Covidien

    April 29, 2013
    Expectations are the bigger issue for Covidien, as underlying growth is still pretty good on a relative basis.
  2. Is Controversy About Robot-Assisted Surgery Showing In ...

    April 19, 2013
    Uncertainty about procedure growth may be opening a window in these often-expensive shares
  3. Pharma Is Doing All The Pulling For Johnson & Johnson

    April 17, 2013
    Although JNJ reported decent earnings and has some major new drugs lined up - downside risk is definitely still present.
  4. AngioDynamics Still Struggling To Get Back On Track

    April 10, 2013
    Ongoing revenue growth struggles and eroding market share is making the deep-value case harder at AngioDynamics.
  5. Masimo's Mixed 4Q, Profit Up - Analyst Blog

    February 15, 2013
    Masimo Corporation (MASI), a leader in non-invasive monitoring technology for patient care, recorded fourth quarter ...
  6. Hospira Beats by a Penny - Analyst Blog

    February 14, 2013
    Hospira Inc.'s (HSP) fourth quarter 2012 earnings (excluding special items) of 55 cents per share beat the Zacks ...
  7. Hanger Beats Squarely; Profit Soars - Analyst Blog

    February 14, 2013
    Hanger Inc.'s (HGR) adjusted earnings of 58 cents per share for the fourth quarter of 2012 were 2 cents above the ...
  8. St. Jude Recalls Amplatzer Device - Analyst Blog

    February 13, 2013
    Medical devices major St. Jude Medical Inc. (STJ) is voluntarily recalling its Amplatzer TorqVue FX Delivery System ...
  9. Covidien Issues STAR Trial Data - Analyst Blog

    February 08, 2013
    International health care products major, Covidien plc. (COV) announced results of the two-year "Solitaire FR ...
  10. Brightcove Reports Mixed 4Q - Analyst Blog

    February 05, 2013
    Brightcove Inc. (BCOV) reported a loss of 13 cents in the fourth quarter of 2012, wider than the Zacks Consensus ...
  11. Libya First to Adopt Pronto-7 - Analyst Blog

    February 04, 2013
    Masimo Corporation (MASI), a leader in non-invasive monitoring technology, recently revealed that Libya is the first ...
  12. Shabby Reporting And Questionable Prospects At Abbott Labs

    January 28, 2013
    Poor reporting and weak margins undermine the potential of Abbott.
  13. Covidien's 1Q Beats, Raises View - Analyst Blog

    January 25, 2013
    Covidien plc. (COV) reported its adjusted earnings per share of $1.10 for the first quarter of fiscal 2013, 4 cents ...
  14. Earnings Preview: Covidien - Analyst Blog

    January 23, 2013
    Health care products major Covidien plc (COV) is scheduled to release its third-quarter fiscal 2012 results before ...
  15. Teleflex Wins GPO Agreement - Analyst Blog

    January 22, 2013
    Teleflex Incorporated (TFX), a global provider of medical devices used in critical care and surgery, recently won a ...
  16. Covidien Wins FDA Approval - Analyst Blog

    January 22, 2013
    International health care product major, Covidien plc. (COV) recently revealed approval from the Food and Drug ...
  17. Covidien's Device for Hypertension - Analyst Blog

    January 21, 2013
    International health care product major, Covidien plc. (COV) recently revealed the commercialization of its OneShot ...
  18. Covidien Begins SWIFT PRIME Study - Analyst Blog

    January 15, 2013
    International health care product major, Covidien plc. (COV), has initiated a new study, SWIFT PRIME. The main ...
  19. Covidien Closes CV Ingenuity Buyout - Analyst Blog

    January 11, 2013
    Large-cap medical technologies company, Covidien plc. (COV) has successfully completed the acquisition of Fremont, ...
  20. Masimo to Display iSpO2 at CES - Analyst Blog

    January 08, 2013
    Masimo Corporation (MASI), a leader in non-invasive monitoring technology, unveiled its iSpO2 pulse oximeter cable ...
Marketplace
Trading Center